Finally, tumor cells hijack organismal glucose and lipid metabolism to thrive; thus, it is not surprising that they can affect β-cell function by releasing exosomes carrying miR-122 that targets PKM2 and decreases glycolysis, hence decreasing ATP-stimulated insulin release and impairing glucose metabolism to favor tumor growth [135]. This evidence concerns the gene INS and neoplasm.